Form 4 for BCAX Bicara Therapeutics Inc.
Accepted 2025-10-01 00:00:00 ET · period of report 2025-09-29 · accession 0001883986-25-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-01 | 2025-09-29 | BCAX | Meisner Lara | CLO | M - OptEx | $9.24 | +33.8K | 33.8K | New | +$312.4K |
| D | 2025-10-01 | 2025-09-29 | BCAX | Meisner Lara | CLO | S - Sale+OE | $14.75 | -33.8K | 0 | -100% | -$498.7K |
| D | 2025-10-01 | 2025-09-29 | BCAX | Meisner Lara | CLO | M - OptEx | $0.00 | -33.8K | 101.4K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-29 | M | A | 33,807 | $9.24 | 33,807 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-29 | S | D | 33,807 | $14.75 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-09-29 | M | D | 33,807 | $0.00 | 101,423 | D | $9.24 · — to 2034-08-13 | 33,807 Common Stock | (F2) 25% of the shares underlying this option vested on August 13, 2025, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |